OA-235i

N/A

Report date: 2023/01/12 20:00:37
NME

Base Information

Drug NameOA-235i
Drug Alias NameOA-235i
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionProtease-activated receptor-2 antagonists
TargetsProtease-activated receptor-2
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesOasis Pharmaceuticals LLC
China Registration ClassN/A

Develop Information

Active CompaniesOasis Pharmaceuticals LLC
Inactive CompaniesN/A
Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A